Letter to the Editor
Vector-Borne Diseases - constant challenge for practicing veterinarians: recommendations from the CVBD World Forum
1 Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel
2 Unité de Dermatologie, Parasitologie CE, Mycologie, Ecole Nationale Vétérinaire, Agroalimentaire et de l'Alimentation, Nantes-Atlantique (ONIRIS), France
3 Unité de Parasitologie, Mycologie, Maladies Parasitaires, Ecole Nationale Vétérinaire de Lyon, Marcy L'Etoile, France
4 Department Microbiology & Immunology, College of Veterinary Medicine, Cornell University, Ithica, NY, USA
5 Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA
6 Laboratorio di Parassitologia e Ecopatologia, Istituto Zooprofi lattico Sperimentale delle Venezie, Legnaro-Padova, Italy
7 Department of Veterinary Sciences, University of Trás-os-Montes e Alto Douro, Vila Real, Portugal
8 Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Brazil
9 School of Veterinary Sciences, University of Bristol, Langford, Bristol, UK
10 Laboratoire de Parasitologie-Mycologie du CHU de Montpellier, UMR MIVEGEC, Centre National de Référence des Leishmania, Montpellier, France
11 Department of Virology and Rickettsiology, Bundeswehr Institute of Microbiology, Munich, Germany
12 Department of Animal Medicine and Surgery, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain
13 School of Veterinary and Biomedical Sciences, Division of Health Sciences, Murdoch University, Murdoch, Western Australia, Australia
14 Institut für Medizinische Mikrobiologie und Krankenhaushygiene, Klinikum der Goethe-Universität, Frankfurt am Main, Germany
15 Clinic of Small Animals, Faculty of Veterinary Medicine, Free University of Berlin, Berlin, Germany
16 Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA
17 Department of Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, USA
18 Intracellular Pathogens Research Laboratory, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA
19 Dpto. Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain
20 Department of Zoology - Division of Parasitology, University of Hohenheim, Stuttgart, Germany
21 Dip. to di Scienze Cliniche Veterinarie, Universita di Napoli, Naples, Federico II, Italy
22 Department of Veterinary Public Health, Faculty of Veterinary Medicine, University of Bari, Valenzano, Bari, Italy
23 Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, Pretoria, South Africa
24 Institut für Tierhygiene und Öffentliches Veterinärwesen, Veterinärmedizinische Fakultät, Universität Leipzig, Leipzig, Germany
25 Servei de Medicina Interna, Hospital Clínic Veterinari, Facultat de Veterinària, Universitat Autònoma de Barcelona, Bellaterra (Barcelona), Spain
26 Dpto. de Medicina y Cirugía Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain
27 School of Clinical Veterinary Science, University of Bristol, Langford, Bristol, UK
28 College of Veterinary Medicine, Chonnam National University, Gwangju, South Korea
29 Department of Animal Medicine and Surgery, Universitat Autònoma de Barcelona, Bellatorra, Barcelona, Spain
30 Lehrstuhl für Bakteriologie und Mykologie, Veterinärwissenschaftliches Department, Tierärztliche Fakultät, Ludwig-Maximilians-Universität München, Munich, Germany
31 School of Veterinary Science, The University of Queensland, Queensland, Australia
32 Infection Biology Group, Comparative Molecular Medicine, School of Veterinary Science, University of Liverpool, Liverpool, UK
33 Institut für Tierhygiene und Öffentliches Veterinärwesen, Veterinärmedizinische Fakultät, Universität Leipzig, Leipzig, Germany
34 Bayer Santé SAS, Puteaux, France
35 Bayer Plc, Animal Health Division, Newbury, UK
36 Bayer HealthCare Italy, Animal Health Division, Milan, Italy
37 Bayer HealthCare LLC, Animal Health, Shawnee Mission, KS, USA
38 Bayer Inc., Bayer HealthCare - Animal Health, Toronto, Canada
39 Bayer Animal Health GmbH, Monheim, Germany
40 Bayer Animal Health GmbH, Monheim, Germany
41 Bayer Portugal S.A., Animal Health Division, Carnaxide, Portugal
42 Bayer Animal Health GmbH, Monheim, Germany
43 Bayer Vital GmbH, Leverkusen, Germany
44 Bayer Australia, Animal Health Division, Brisbane, Australia
45 Bayer Animal Health GmbH, Monheim, Germany
46 Bayer Animal Health GmbH, Monheim, Germany
47 Bayer HealthCare Spain, Animal Health Division, Barcelona, Spain
48 Bayer HealthCare LLC, Animal Health, Shawnee Mission, KS, USA
49 Bayer New Zealand Ltd, Auckland, New Zealand
Parasites & Vectors 2012, 5:55 doi:10.1186/1756-3305-5-55
Published: 20 March 2012Abstract
The human-animal bond has been a fundamental feature of mankind's history for millennia. The first, and strongest of these, man's relationship with the dog, is believed to pre-date even agriculture, going back as far as 30,000 years. It remains at least as powerful today. Fed by the changing nature of the interactions between people and their dogs worldwide and the increasing tendency towards close domesticity, the health of dogs has never played a more important role in family life. Thanks to developments in scientific understanding and diagnostic techniques, as well as changing priorities of pet owners, veterinarians are now able, and indeed expected, to play a fundamental role in the prevention and treatment of canine disease, including canine vector-borne diseases (CVBDs).
The CVBDs represent a varied and complex group of diseases, including anaplasmosis, babesiosis, bartonellosis, borreliosis, dirofilariosis, ehrlichiosis, leishmaniosis, rickettsiosis and thelaziosis, with new syndromes being uncovered every year. Many of these diseases can cause serious, even life-threatening clinical conditions in dogs, with a number having zoonotic potential, affecting the human population.
Today, CVBDs pose a growing global threat as they continue their spread far from their traditional geographical and temporal restraints as a result of changes in both climatic conditions and pet dog travel patterns, exposing new populations to previously unknown infectious agents and posing unprecedented challenges to veterinarians.
In response to this growing threat, the CVBD World Forum, a multidisciplinary group of experts in CVBDs from around the world which meets on an annual basis, gathered in Nice (France) in 2011 to share the latest research on CVBDs and discuss the best approaches to managing these diseases around the world.
As a result of these discussions, we, the members of the CVBD Forum have developed the following recommendations to veterinarians for the management of CVBDs.
